RS1 rs121912531: Understanding the Genetic Basis of Retinoschisis
The rs121912531 variant is a specific genetic change located within the RS1 gene, which provides instructions for producing the retinoschisin protein. This variant is associated with X-linked juvenile retinoschisis, a condition characterized by the splitting of retinal layers and vision loss.
What each genotype means
Typical RS1 genotype
This genotype represents the common, non-pathogenic sequence for the RS1 gene in the general population. It is associated with the normal production of the retinoschisin protein, which is essential for maintaining the structural integrity of the retina.
This is the most common genotype found in the vast majority of the human population.
Potential pathogenic variant carrier
This genotype indicates the presence of a specific missense substitution in the RS1 gene. Because RS1 is X-linked, this variant is primarily associated with X-linked juvenile retinoschisis in males, a condition characterized by the splitting of retinal layers and progressive vision loss. If you are concerned about your vision or family history, please consult with a genetic counselor or ophthalmologist.
This specific variant is extremely rare, with a reported allele frequency of less than 0.00001 in large-scale population databases like gnomAD.
What is the rs121912531 Variant?
The variant rs121912531 is a missense substitution located within the RS1 gene on the X chromosome. In genetics, a missense mutation occurs when a single nucleotide change results in the substitution of one amino acid for another in the final protein product. Because this variant is located on the X chromosome, it follows an X-linked inheritance pattern. This means that males, who have only one X chromosome, are primarily affected by variants in this gene, as they lack a second copy to compensate for any loss of function. The specific change at this position can alter the structure or stability of the resulting protein, potentially impacting its ability to perform its normal biological tasks within the eye.
The Role of the RS1 Gene
The RS1 gene is responsible for producing a protein called retinoschisin. This protein is secreted by cells in the retina and plays a critical role in maintaining the structural integrity and organization of retinal layers. Retinoschisin acts as a cell-adhesion protein, helping to keep the layers of the retina properly stratified and supporting the health of photoreceptor cells. When the RS1 gene is mutated, the production or function of retinoschisin is often compromised. This disruption can lead to the splitting of the inner retinal layers, a process known as schisis. This structural failure is the hallmark of X-linked juvenile retinoschisis, which can lead to significant visual impairment, particularly in the macula, the area of the retina responsible for sharp, central vision.
Research and Clinical Associations
Research into rs121912531 and other RS1 variants has established a clear link to X-linked juvenile retinoschisis. Clinical studies indicate that pathogenic variants in this gene are the primary cause of this condition. The evidence for this association is strong, as the gene's function is well-documented in both human clinical cases and animal models. However, the severity of the condition can vary significantly between individuals, even those with the same variant. This variability may be influenced by the specific nature of the mutation, as some missense variants may allow for residual protein function, leading to milder clinical features compared to truncating mutations that result in a complete loss of protein. It is important to note that identifying a variant does not replace a clinical diagnosis, which requires a comprehensive eye examination by a specialist.
Population Frequency
The rs121912531 variant is extremely rare in the general population, with an allele frequency reported in databases like gnomAD as less than 0.00001. Because it is associated with a rare inherited condition, it is not commonly found in the general public. The prevalence of X-linked juvenile retinoschisis itself is estimated to be between 1 in 5,000 and 1 in 25,000 individuals. Due to its rarity, most people will never encounter this variant. Genetic testing for such variants is typically reserved for individuals with a family history of retinal dystrophy or those presenting with specific clinical symptoms, rather than as part of routine population screening.
What You Can Do With This Information
If you or a family member have been identified as a carrier of an RS1 variant, the most important step is to consult with a medical professional, such as a genetic counselor or an ophthalmologist specializing in retinal diseases. They can help interpret what this means in the context of your personal and family health history. You cannot use this information to diagnose yourself or others, and there is no 'lifestyle' change that can alter a genetic variant. Instead, focus on regular eye health monitoring and discussing any vision changes with your clinician. If you are considering genetic testing, ensure it is performed in a certified laboratory and that you have access to professional genetic counseling to understand the implications of the results for you and your family members.
How common is this variant?
The rs121912531 variant is extremely rare, with a reported allele frequency of less than 0.00001 in the gnomAD database.
Frequently asked questions
What is X-linked juvenile retinoschisis?
It is an inherited eye disorder that causes the layers of the retina to split, leading to reduced vision. It primarily affects males and is caused by mutations in the RS1 gene.
Can I be a carrier of an RS1 mutation?
Yes, females can be carriers of X-linked conditions like those involving the RS1 gene. Carriers typically do not show symptoms but can pass the variant to their children.
Is there a cure for RS1-related retinoschisis?
Currently, there is no cure for the underlying genetic cause of X-linked juvenile retinoschisis. Management focuses on monitoring vision and addressing complications with the help of an ophthalmologist.
Should I get tested for this variant?
Genetic testing is generally recommended only if you have a family history of retinal disease or specific clinical symptoms. Discuss the necessity of testing with a genetic counselor or your doctor.
Sources & further reading
Educational information only, last refreshed 9/22/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912531?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in RS1
Pathogenic missense variant disrupting the discoidin domain of retinoschisin, causing X-linked juvenile retinoschisis.
Encodes the Arg102Gln missense variant in retinoschisin, causing X-linked juvenile retinoschisis with macular splitting and reduced central vision.
An X-linked missense variant in retinoschisin leading to X-linked juvenile retinoschisis and early macular splitting.
Pathogenic splice/missense variant in RS1 implicated in X-linked juvenile retinoschisis with characteristic macular splitting and decreased visual acuity.
An X-linked missense substitution (p.Glu72Lys) in the retinoschisin gene disrupting discoidin domain function and causing juvenile X-linked retinoschisis.